1,4-dihydropyridine has been researched along with methamphetamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ait-Daoud, N; Bordnick, PS; Johnson, BA; Roache, JD | 1 |
| Ait-Daoud, N; Johnson, BA; Wells, LT | 1 |
2 trial(s) available for 1,4-dihydropyridine and methamphetamine
| Article | Year |
|---|---|
Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study.
Topics: Adrenergic Agents; Adult; Affect; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Double-Blind Method; Drug Antagonism; Female; Humans; Isradipine; Male; Methamphetamine; Middle Aged; Reinforcement, Psychology; Reward; Substance-Related Disorders | 1999 |
Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on D-methamphetamine-induced cognitive and physiological changes in humans.
Topics: Adult; Amphetamine-Related Disorders; Calcium Channel Blockers; Cardiovascular Physiological Phenomena; Cognition; Cross-Over Studies; Dihydropyridines; Double-Blind Method; Female; Humans; Isradipine; Male; Methamphetamine; Middle Aged; Nootropic Agents | 2000 |